TETRA Technologies, Inc. (TTI), an energy services company listed on the NYSE, carries a "Strong Buy" aggregate rating from the four analysts with current, attributable targets. The verified targets reviewed are $10.00 (Northland Securities, Buy), $11.00 (Stifel Nicolaus, Buy), $11.00 (Clear Street, Buy), and $11.50 (CJS Securities, Outperform). Their arithmetic mean is $10.88, rounded to a clean $11 for this analysis, with an approximate low-to-high range of $10.00 to $11.50.
That narrow range reflects broad agreement rather than dispersion. Bulls emphasize the company's growth projects, while more cautious voices point to near-term earnings estimates that have been reset lower. Recent actions show mixed momentum: Clear Street upgraded the stock to Buy in October 2026, while Stifel trimmed its target to $11 from $12 in early November, and Northland cut to $10 from $14 in September after refining its 2027 assumptions. The mean is a calculation of individual targets, not an official published consensus, and should not be read as a guarantee. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With shares near $6.00, the stock would need to rise about 83% to reach the $11 central target, a very large move. After trading as high as $12.54 over the past year, TTI has pulled back sharply toward its 52-week low of $4.87. The company operates two segments—Completion Fluids & Products and Water & Flowback Services—and reported a third-quarter earnings beat in early November: EPS of $0.06 versus a $0.05 consensus, with revenue of roughly $168 million against expectations near $157 million. Despite the beat, the shares remain depressed, reflecting thin net margins (about 1.4% net margin on roughly $656 million in trailing revenue) and valuation sensitivity to the energy cycle.
Several verified catalysts could support a recovery. The company's Evergreen bromine project in Arkansas, part of its "ONE TETRA 2030" strategy, received a conditional final investment decision and represents a potential step-change in earnings if executed. Water desalination and the PureFlow electrolyte line, which ties TTI to the battery energy storage theme through customers such as Eos Energy, are longer-dated but meaningful growth narratives. International expansion and completion-fluid demand also contributed to the latest quarterly beat. Northland recently raised its full-year 2026 EPS estimate, and insider buying has been reported, both modestly supportive signals. From what I see, these elements warrant close attention in the quarters ahead.
The risks are equally clear. Energy services remain cyclical and sensitive to oil and gas activity and commodity prices. The company's margins are thin, leaving little room for error, and valuation is not obviously cheap relative to current earnings. The Evergreen project is capital-intensive and carries financing and execution risk, while desalination and electrolyte contributions are still emerging rather than established. Thin analyst coverage means a single downgrade or estimate cut can move the picture noticeably, and Northland's own September target cut from $14 to $10 illustrates how quickly expectations can reset. Continued estimate pressure or a weaker energy macro environment could keep the shares range-bound.
The stock trades below its 50-day moving average near $6.08 and well below its 200-day moving average near $8.64, indicating a longer-term downtrend from the 52-week high. The $4.87 52-week low is the key downside reference, while the $8.60 to $9.00 zone, where the 200-day average and prior consolidation sit, is a notable resistance area that would likely need to be reclaimed before a move toward the target becomes credible. The $11 level itself is a psychological round number and sits just below the top of the analyst range. I’m watching this closely for any signs of stabilization here.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms may differ and no timing is guaranteed. Investors should monitor the next quarterly earnings and any updated guidance, progress and financing on the Evergreen project, analyst estimate revisions (which have been volatile), desalination and electrolyte commercial updates, and broader oil and gas activity data. Changes to any single target can shift the small consensus meaningfully.
For a data-driven complement to fundamental research, I often turn to Tickeron's AI Daily Buy/Sell Signals. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. It helps me discover new opportunities, monitor existing positions, and spot shifting trends more efficiently than manual scanning allows. I find it useful to review these signals alongside my own analysis as conditions evolve.
The $11 central target represents an 83% move from a share price near $6.00, making it an ambitious but not impossible objective if TETRA Technologies' growth projects translate into earnings. The strongest supports are the Evergreen bromine project, the desalination and electrolyte narratives, and a recent earnings beat, while the principal obstacles are thin margins, execution and financing risk, a downtrend in the shares, and a small analyst base whose targets have been drifting lower. Analyst views are broadly bullish but clustered in a narrow $10.00 to $11.50 range, and no target should be treated as a guarantee. Investors should watch earnings, guidance, project milestones, and estimate revisions for the clearest signal on whether the gap toward $11 can begin to close.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TTI advanced for three days, in 238 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TTI's RSI Indicator exited the oversold zone, 15 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on TTI as a result. In 66 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for TTI just turned positive on October 26, 2026. Looking at past instances where TTI's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.
TTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
TTI moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for TTI entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. TTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 75 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.179) is normal, around the industry mean (1.488). P/E Ratio (150.000) is within average values for comparable stocks, (-21.917). Projected Growth (PEG Ratio) (2.340) is also within normal values, averaging (1.687). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (1.350) is also within normal values, averaging (1.663).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of chemicals, associated products and services to the oil and gas industry
Industry OilfieldServicesEquipment